Updated 13/09/2026
Vitamin E is the nutrient almost everybody is short of and almost nobody is clinically deficient in. That paradox is real, and it shapes everything about how the vitamin should be discussed: the intake gap is enormous and well documented, overt deficiency disease is rare because the body hoards the vitamin, and the question of which form to take turns on a single liver protein that has a strong opinion about molecular shape. This article walks through the numbers, then the biology, without overselling either.
The intake gap: how large, and how consistent
The estimated average requirement (EAR) for α-tocopherol — the amount that meets the needs of half the population — is 12 mg/day in the US framework, with the recommended allowance set at 15 mg. Against that benchmark, US national survey data show that roughly 90% of adults fall below the EAR from food alone; the proportion falls to about two-thirds only when fortified foods and supplements are included (Fulgoni et al. 2011). A systematic review of intake and blood-level studies across 46 countries found that 82% of people in the pooled intake data consumed less than the 15 mg reference, and that about 13% of the blood-concentration studies reported serum α-tocopherol below the 12 µmol/L threshold associated with increased risk (Péter et al. 2015). The European authority took a different approach in 2015, setting an “adequate intake” of 13 mg for men and 11 mg for women rather than a requirement, precisely because the evidence linking intake to hard outcomes was judged insufficient to set an EAR (EFSA 2015). The practical picture is the same under either framework: typical diets — low in nuts, seeds, wheat germ and unrefined plant oils — supply 6–10 mg, and most people are well below any reference value.
Why this rarely becomes deficiency disease
Clinical vitamin E deficiency — peripheral neuropathy, ataxia, retinopathy, haemolytic anaemia — is seen almost exclusively in people who cannot absorb fat (cystic fibrosis, cholestatic liver disease, short bowel, abetalipoproteinaemia) or who carry mutations in the transfer protein discussed below. In everyone else, body stores in adipose tissue are large and turnover is slow, so a chronically low intake produces low-normal plasma levels rather than disease. The significance of a long-term low-normal state is debated. A review of the causes and consequences of inadequacy argues that the requirement was set largely on the basis of preventing red-cell fragility, and that functional consequences of chronic marginal intake — on neurological and immune function particularly — are plausible but under-studied (Traber 2014). The honest statement is: the gap is real, the consequences are uncertain, and correcting intake to the reference level is a low-risk, evidence-consistent step rather than a proven disease-preventing one.
The liver’s gatekeeper: α-tocopherol transfer protein
Here the form question begins. “Vitamin E” in nature is a family of eight molecules — four tocopherols and four tocotrienols — and the body treats only one of them, α-tocopherol, as the vitamin. The reason is a hepatic protein called α-tocopherol transfer protein (α-TTP). After any fat-soluble vitamin E form is absorbed and reaches the liver in chylomicron remnants, α-TTP selects α-tocopherol and loads it onto very-low-density lipoproteins for export to the rest of the body; the other forms are preferentially metabolised and excreted. Affinity studies quantified the selectivity: relative to RRR-α-tocopherol at 100%, β-tocopherol binds at 38%, γ-tocopherol at 9% and δ-tocopherol at 2% (Hosomi et al. 1997). People born without functional α-TTP develop severe neurological deficiency despite normal intake — proof that the protein, not absorption, is the rate-limiting step for keeping vitamin E in the body.
Natural versus synthetic: the 2:1 that the pharmacopoeias accepted
α-Tocopherol has three chiral centres, so it exists in eight stereoisomers. Nature makes one: RRR-α-tocopherol (labelled “d-α-tocopherol”). Chemical synthesis makes all eight in equal amounts: all-rac-α-tocopherol (“dl-α-tocopherol”). α-TTP prefers the 2R configurations and handles the four 2S isomers poorly, so half of a synthetic dose is discriminated against at the liver. The decisive human study fed volunteers deuterium-labelled natural and synthetic vitamin E simultaneously and followed the isotopes in plasma and tissues: the natural form was retained at roughly twice the concentration of the synthetic form — a ratio closer to 2:1 than the 1.36:1 that older, rat-based potency units had assumed (Burton et al. 1998). The US Institute of Medicine accepted this in 2000, defining the requirement in terms of 2R-stereoisomers only and counting synthetic all-rac at half value (IOM 2000). On a label this means that 15 mg of RRR-α-tocopherol and 30 mg of all-rac-α-tocopherol are, for the purpose of meeting the requirement, approximately the same dose — and that “IU” figures, still widely used, obscure the difference.
What a buyer should look for — and what not to overdo
On the ingredient list, “d-α-tocopherol” or “RRR-α-tocopherol” (often as the acetate or succinate ester for stability) indicates the natural form; “dl-α-tocopherol” or “all-rac” indicates synthetic. Mixed tocopherols (α with γ and δ) from plant oils mirror the dietary pattern and are a reasonable choice; tocotrienols are a separate topic. Doses should be judged against the reference value (NRV explained): the EU tolerable upper level is 300 mg/day, and large outcome trials of 400 IU (about 270–400 mg depending on form) and above have shown no benefit and, in meta-analysis, a signal of harm — so closing the gap to 12–15 mg is the evidence-based target, not megadosing. As an oil-soluble, oxidation-prone molecule, vitamin E is best delivered in an oil matrix, protected from light and heat (why liquid oil drops; how heat destroys potency), and taken with a meal containing fat.
The clinical bottom line
Around 80–90% of adults consume less vitamin E than reference values, though overt deficiency is rare because stores are large and the long-term consequences of marginal intake are uncertain. The liver’s α-tocopherol transfer protein selects natural RRR-α-tocopherol and retains it at roughly twice the rate of the synthetic all-rac mixture, a 2:1 ratio adopted by the Institute of Medicine. The evidence supports closing the gap to 12–15 mg/day with the natural form in an oil matrix — and stopping there.
Primary sources
- Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients? J Nutr. 2011;141(10):1847–1854. doi:10.3945/jn.111.142257
- Péter S, Friedel A, Roos FF, et al. A systematic review of global alpha-tocopherol status as assessed by nutritional intake levels and blood serum concentrations. Int J Vitam Nutr Res. 2015;85(5–6):261–281. doi:10.1024/0300-9831/a000281
- Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014;5(5):503–514. doi:10.3945/an.114.006254
- Hosomi A, Arita M, Sato Y, et al. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997;409(1):105–108. doi:10.1016/S0014-5793(97)00499-7
- Burton GW, Traber MG, Acuff RV, et al. Human plasma and tissue α-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr. 1998;67(4):669–684. doi:10.1093/ajcn/67.4.669
- Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press; 2000. doi:10.17226/9810
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for vitamin E as α-tocopherol. EFSA J. 2015;13(7):4149. doi:10.2903/j.efsa.2015.4149
Educational information on supplement quality and consumer protection, not medical advice.
🗺️ Find certified Georgian healthcare providers: sheniekimi.ge — Georgia Health Map · 998 clinics · 6,600+ doctors · 2,296 pharmacies
Was this article helpful?
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
